• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

流行病学与抗真菌策略

: Epidemiology and Antifungal Strategy.

作者信息

Eix Emily F, Nett Jeniel E

机构信息

Department of Medicine and Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, Wisconsin, USA; email:

出版信息

Annu Rev Med. 2025 Jan;76(1):57-67. doi: 10.1146/annurev-med-061523-021233. Epub 2025 Jan 16.

DOI:10.1146/annurev-med-061523-021233
PMID:39656947
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11808652/
Abstract

is a recently emerged fungal pathogen that causes severe infections in healthcare settings around the globe. A feature that distinguishes from other fungal pathogens is its high capacity to colonize skin, leading to widespread outbreaks in healthcare facilities via patient-to-patient transmission. can persist on skin or in the surrounding environment for extended periods of time, and it exhibits greater antifungal resistance than other species. These factors pose major obstacles for the prevention and treatment of infection. Recent reports have identified frequently colonized skin sites, risk factors for developing invasive infection, and patterns of antifungal resistance among strains, all of which help guide therapeutic options. In this review, we highlight key studies of epidemiology and antifungal resistance, discussing how these factors influence healthcare-associated transmission and treatment outcomes.

摘要

是一种最近出现的真菌病原体,在全球医疗机构中引起严重感染。与其他真菌病原体不同的一个特征是其在皮肤上定殖的能力很强,通过患者之间的传播在医疗机构中导致广泛的暴发。它可以在皮肤或周围环境中长期存活,并且比其他物种表现出更强的抗真菌耐药性。这些因素对感染的预防和治疗构成了重大障碍。最近的报告已经确定了经常定殖的皮肤部位、发生侵袭性感染的危险因素以及菌株中的抗真菌耐药模式,所有这些都有助于指导治疗选择。在这篇综述中,我们重点介绍了关于该病原体流行病学和抗真菌耐药性的关键研究,讨论了这些因素如何影响医疗相关传播和治疗结果。

需注意,原文中多次出现未明确的指代,翻译时按“该病原体”等表述处理,实际应用中应结合具体所指对象准确翻译。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ec4/11808652/f86e241c4b78/nihms-2053603-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ec4/11808652/f86e241c4b78/nihms-2053603-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ec4/11808652/f86e241c4b78/nihms-2053603-f0001.jpg

相似文献

1
: Epidemiology and Antifungal Strategy.流行病学与抗真菌策略
Annu Rev Med. 2025 Jan;76(1):57-67. doi: 10.1146/annurev-med-061523-021233. Epub 2025 Jan 16.
2
Candida auris: Epidemiology, risk factors, virulence, resistance, and therapeutic options.耳念珠菌:流行病学、风险因素、毒力、耐药性和治疗选择。
Microb Pathog. 2018 Dec;125:116-121. doi: 10.1016/j.micpath.2018.09.014. Epub 2018 Sep 8.
3
Candida auris: The recent emergence of a multidrug-resistant fungal pathogen.耳念珠菌:一种近期出现的多重耐药真菌病原体。
Med Mycol. 2019 Jan 1;57(1):1-12. doi: 10.1093/mmy/myy054.
4
Candida auris: an Emerging Fungal Pathogen.耳念珠菌:一种新兴的真菌病原体。
J Clin Microbiol. 2018 Jan 24;56(2). doi: 10.1128/JCM.01588-17. Print 2018 Feb.
5
The laboratory investigation, management, and infection prevention and control of : a narrative review to inform the 2024 national guidance update in England.实验室调查、管理以及感染预防和控制:一篇叙述性综述,旨在为 2024 年英格兰国家指南更新提供信息。
J Med Microbiol. 2024 May;73(5). doi: 10.1099/jmm.0.001820.
6
Key Factors to Consider for Candida auris Screening in Healthcare Settings: A Systematic Review.医疗机构中开展耳念珠菌筛查需考虑的关键因素:一项系统综述
Mycoses. 2025 Mar;68(3):e70043. doi: 10.1111/myc.70043.
7
Candida auris in Greek healthcare facilities: Active surveillance results on first cases and outbreaks from eleven hospitals within Attica region.希腊医疗机构中的耳念珠菌:来自阿提卡地区 11 家医院的首例病例和暴发的主动监测结果。
J Mycol Med. 2024 Jun;34(2):101477. doi: 10.1016/j.mycmed.2024.101477. Epub 2024 Mar 26.
8
Two outbreaks and sporadic occurrences of Candida auris from one hospital in China: an epidemiological, genomic retrospective study.中国一家医院的两起耳念珠菌暴发及散发病例:一项流行病学、基因组回顾性研究
Infection. 2025 Feb;53(1):349-358. doi: 10.1007/s15010-024-02378-8. Epub 2024 Aug 26.
9
Independent introductions and nosocomial transmission of in Saudi Arabia ─ a genomic epidemiological study of an outbreak from a hospital in Riyadh.沙特阿拉伯的独立引入与医院内传播——利雅得一家医院疫情的基因组流行病学研究
Microbiol Spectr. 2025 Mar 4;13(3):e0326024. doi: 10.1128/spectrum.03260-24. Epub 2025 Feb 4.
10
Approach to the Investigation and Management of Patients With Candida auris, an Emerging Multidrug-Resistant Yeast.《耳念珠菌(一种新兴的耐多药酵母)患者的调查和管理方法》
Clin Infect Dis. 2018 Jan 6;66(2):306-311. doi: 10.1093/cid/cix744.

引用本文的文献

1
Innovative antifungal strategies to combat drug-resistant : recent advances and clinical implications.对抗耐药性的创新抗真菌策略:最新进展与临床意义
Front Cell Infect Microbiol. 2025 Jul 31;15:1641373. doi: 10.3389/fcimb.2025.1641373. eCollection 2025.
2
Diagnostic Approaches for : A Comprehensive Review of Screening, Identification, and Susceptibility Testing.针对……的诊断方法:筛查、识别及药敏试验的全面综述
Microorganisms. 2025 Jun 24;13(7):1461. doi: 10.3390/microorganisms13071461.
3
Growth phase influences virulence in systemic infection models.

本文引用的文献

1
Plastic pollution as a novel reservoir for the environmental survival of the drug resistant fungal pathogen Candida auris.塑料污染作为耐药真菌病原体耳念珠菌环境生存的新储层。
Mar Pollut Bull. 2024 Jan;198:115841. doi: 10.1016/j.marpolbul.2023.115841. Epub 2023 Dec 6.
2
Candida auris Blood stream infection- a descriptive study from Qatar.Candida auris 血流感染-来自卡塔尔的描述性研究。
BMC Infect Dis. 2023 Aug 6;23(1):513. doi: 10.1186/s12879-023-08477-5.
3
Detection of the clinically persistent, pathogenic yeast spp. Candida auris from hospital and municipal wastewater in Miami-Dade County, Florida.
生长阶段会影响全身感染模型中的毒力。
bioRxiv. 2025 Jun 2:2025.06.02.657403. doi: 10.1101/2025.06.02.657403.
4
Resilience in Resistance: The Role of Cell Wall Integrity in Multidrug-Resistant Candida.耐药中的抗逆性:细胞壁完整性在多重耐药念珠菌中的作用
J Fungi (Basel). 2025 Apr 1;11(4):271. doi: 10.3390/jof11040271.
5
Therapeutic potential of mesenchymal stem cells for fungal infections: mechanisms, applications, and challenges.间充质干细胞在真菌感染治疗中的潜力:机制、应用与挑战
Front Microbiol. 2025 Jan 30;16:1554917. doi: 10.3389/fmicb.2025.1554917. eCollection 2025.
从佛罗里达州迈阿密-戴德县的医院和市政废水中检测到具有临床持久性的致病性酵母 spp. 耳念珠菌。
Sci Total Environ. 2023 Nov 10;898:165459. doi: 10.1016/j.scitotenv.2023.165459. Epub 2023 Jul 12.
4
Candida auris‒Associated Hospitalizations, United States, 2017-2022.2017-2022 年美国与耳念珠菌相关的住院情况。
Emerg Infect Dis. 2023 Jul;29(7):1485-1487. doi: 10.3201/eid2907.230540.
5
Clinical Efficacy and Safety of a Novel Antifungal, Fosmanogepix, in Patients with Candidemia Caused by Candida auris Results from a Phase 2 Trial.新型抗真菌药物 Fosmanogepix 治疗耳念珠菌血症的临床疗效和安全性:一项 2 期临床试验结果
Antimicrob Agents Chemother. 2023 May 17;67(5):e0141922. doi: 10.1128/aac.01419-22. Epub 2023 Apr 6.
6
Worsening Spread of in the United States, 2019 to 2021.2019 年至 2021 年美国的 COVID-19 恶化传播。
Ann Intern Med. 2023 Apr;176(4):489-495. doi: 10.7326/M22-3469. Epub 2023 Mar 21.
7
PK/PD modeling and simulation of the in vitro activity of the combinations of isavuconazole with echinocandins against Candida auris.PK/PD 模型研究与体外实验模拟伊曲康唑联合棘白菌素类药物抗耳念珠菌活性。
CPT Pharmacometrics Syst Pharmacol. 2023 Jun;12(6):770-782. doi: 10.1002/psp4.12949. Epub 2023 Mar 13.
8
Navigating the New Reality: A Review of the Epidemiological, Clinical, and Microbiological Characteristics of , with a Focus on Children.应对新现实:关于[具体疾病名称未给出]的流行病学、临床和微生物学特征的综述,重点关注儿童。
J Fungi (Basel). 2023 Jan 28;9(2):176. doi: 10.3390/jof9020176.
9
Community-Scale Wastewater Surveillance of during an Ongoing Outbreak in Southern Nevada.在内华达州南部持续爆发期间进行的社区规模污水监测。
Environ Sci Technol. 2023 Jan 31;57(4):1755-1763. doi: 10.1021/acs.est.2c07763. Epub 2023 Jan 19.
10
Confirmation of fifth clade by whole genome sequencing.全基因组测序确认第五分支。
Emerg Microbes Infect. 2022 Dec;11(1):2405-2411. doi: 10.1080/22221751.2022.2125349.